APA (7th ed.) Citation

C, v. A., M, B., C, M., W, H., N, C., J, v. I., . . . A, v. L. (2022). Interleukin-1 receptor antagonist anakinra as treatment for paradoxical responses in HIV-negative tuberculosis patients: A case series. Med (New York, N.Y.), 3(9), 603. https://doi.org/10.1016/j.medj.2022.07.001

Chicago Style (17th ed.) Citation

C, van Arkel, et al. "Interleukin-1 Receptor Antagonist Anakinra as Treatment for Paradoxical Responses in HIV-negative Tuberculosis Patients: A Case Series." Med (New York, N.Y.) 3, no. 9 (2022): 603. https://doi.org/10.1016/j.medj.2022.07.001.

MLA (9th ed.) Citation

C, van Arkel, et al. "Interleukin-1 Receptor Antagonist Anakinra as Treatment for Paradoxical Responses in HIV-negative Tuberculosis Patients: A Case Series." Med (New York, N.Y.), vol. 3, no. 9, 2022, p. 603, https://doi.org/10.1016/j.medj.2022.07.001.